+ND Capital exits CellPoint, via sale to Belgian biotech company Galapagos
“This deal is further validation of our strategy to invest in company creation in Europe," said Patrick Aebischer, Senior Partner at +ND Capital.
22 June 2022•2 mins read
“This deal is further validation of our strategy to invest in company creation in Europe," said Patrick Aebischer, Senior Partner at +ND Capital.
Kohlberg-backed Trinity acquires Verix to add pharma AI execution tools
4 hours ago · 2 mins read
LLCP completes sale of Global Loan Agency Services to Oakley Capital
7 hours ago · 1 min read
Vinci Compass agrees deal for Latin American reinsurer AustralRe
8 hours ago · 2 mins read
TA-backed Diatech Pharmacogenetics acquires German thermal cycler maker SensoQuest
9 hours ago · 1 min read
Broadwing-backed Forte Technologies adds Illinois cybersecurity compliance firm BCSS
10 hours ago · 1 min read
HCAP Partners-backed Real Diagnostics adds saliva-based oral health testing firm SimplyTest
10 hours ago · 1 min read
